Nat. Med. 13, 1102–1107 (2007); published online 2 September 2007; corrected after print 17 September 2007
In the version of this article initially published, the name of one person acknowledged was misspelled, and reference 4 should have been:
Moghaddam, B. & Adams, B.W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281, 1349–1352 (1998).
These errors have been corrected in the HTML and PDF versions of the article.
Additional information
The online version of the original article can be found at 10.1038/nm1632
Rights and permissions
About this article
Cite this article
Patil, S., Zhang, L., Martenyi, F. et al. Correction: Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat Med 13, 1264 (2007). https://doi.org/10.1038/nm1007-1264
Issue Date:
DOI: https://doi.org/10.1038/nm1007-1264
